الفهرس | Only 14 pages are availabe for public view |
Abstract Neonatal sepsis remains a major clinical problem in neonatology, with high morbidity and mortality rates despite the progress in neonatal intensive care and antibiotics. The host defense against infections is immature in the newborn infant, and this makes the neonate more susceptible to intensive infection. The diagnosis of neonatal sepsis begins with clinical suspicion. The challenge for the neonatal practitioner is to decide which babies need empirical antibiotic therapy but this causes antibiotic overuse and nosocomial infections because of unnecessary hospitalization. Unfortunately there is no single diagnostic test, which can reliably diagnose sepsis in the newborn, therefore many diagnostic tests are utilized to diagnose or confirm sepsis. This study was conducted in order to evaluate the prognostic value of Antithrombin III in neonatal sepsis. The present study was carried out at the neonatal intensive care unit (NICU) Shebin El-Kom Teaching Hospital during the period from June 2010 to June 2011. This study includes: Group I :-( STUDY GROUP) It included 40 neonates with sepsis 19 of them survived ,21 died,18 neonates was ill-septic and 22 neonates had DIC. Group II :-( CONTROL GROUP) It included 25 normal neonates. |